Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 transmission in a highly vulnerable population of Brazil: a household cohort study.
Coelho LE, Luz PM, Pires DC, Jalil EM, Perazzo H, Torres TS, Cardoso SW, Peixoto EM, Nazer S, Massad E, Carvalho LM, Réquia WJ, Motta FC, Siqueira MM, Vasconcelos ATR, da Fonseca GC, Cavalcante LTF, Costa CAM, Amancio RT, Villela DAM, Pereira T, Goedert GT, Santos CVBD, Rodrigues NCP, Bormann de Souza Filho BA, Csillag D, Grinsztejn B, Veloso VG, Struchiner CJ. Coelho LE, et al. Among authors: cardoso sw. Lancet Reg Health Am. 2024 Jun 18;36:100824. doi: 10.1016/j.lana.2024.100824. eCollection 2024 Aug. Lancet Reg Health Am. 2024. PMID: 38993539 Free PMC article.
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team. Grinsztejn B, et al. Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18. Lancet HIV. 2018. PMID: 29467098 Clinical Trial.
Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics.
Motta E, Camacho LAB, Filippis AMB, Costa M, Pedro L, Cardoso SW, Souza MCO, Mendes YDS, Grinsztejn B, Coelho LE. Motta E, et al. Among authors: cardoso sw. Braz J Infect Dis. 2024 Jan-Feb;28(1):103719. doi: 10.1016/j.bjid.2024.103719. Epub 2024 Feb 7. Braz J Infect Dis. 2024. PMID: 38341187 Free PMC article.
Frailty and health-related quality of life among older people living with HIV pre- and post-COVID-19 pandemic onset: A cross-sectional study.
Torres TS, Jesus JS, Arabe D, Guaraldo L, Lessa FS, Facchinetti LD, Estrela R, Veloso VG, Grinsztejn B, Cardoso SW. Torres TS, et al. Among authors: cardoso sw. Braz J Infect Dis. 2024 Jan-Feb;28(1):103723. doi: 10.1016/j.bjid.2024.103723. Epub 2024 Feb 15. Braz J Infect Dis. 2024. PMID: 38369295 Free PMC article.
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial.
Coelho LE, Chazallon C, Laureillard D, Escada R, N'takpe JB, Timana I, Messou E, Eholie S, Khosa C, Chau GD, Cardoso SW, Veloso VG, Delaugerre C, Molina JM, Grinsztejn B, Marcy O, De Castro N. Coelho LE, et al. Among authors: cardoso sw. Open Forum Infect Dis. 2024 Jan 22;11(3):ofae035. doi: 10.1093/ofid/ofae035. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38486816 Free PMC article. Clinical Trial.
Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV-ANRS 12403.
Caetano DG, Toledo TS, de Lima ACS, Giacoia-Gripp CBW, de Almeida DV, de Lima SMB, Azevedo AS, Morata M, Grinsztejn B, Cardoso SW, da Costa MD, Brandão LGP, Bispo de Filippis AM, Scott-Algara D, Coelho LE, Côrtes FH. Caetano DG, et al. Among authors: cardoso sw. Vaccines (Basel). 2024 May 25;12(6):578. doi: 10.3390/vaccines12060578. Vaccines (Basel). 2024. PMID: 38932307 Free PMC article.
Exploring the Resurgence of a Neglected Disease: Lessons From the 2023-2024 Mpox Outbreak in Rio de Janeiro, Brazil.
Silva MST, Coutinho C, Torres TS, Magalhães MA, Yanavich C, Echeverría-Guevara A, Bastos MO, Martins PS, Mesquita MB, Reges PPS, Meneguetti MR, Santana APL, Terra M, Nunes EP, Lessa FCS, Moreira RI, Peixoto EM, Paulo KWA, Sant'Ana AC, Elias da Silva E, Cardoso SW, Veloso VG, Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas (INI)–Fiocruz Mpox Study Group. Silva MST, et al. Among authors: cardoso sw. Clin Infect Dis. 2024 Sep 26;79(3):656-659. doi: 10.1093/cid/ciae290. Clin Infect Dis. 2024. PMID: 39012174 Free PMC article.
Patterns of Diversity and Humoral Immunogenicity for HIV-1 Antisense Protein (ASP).
Caetano DG, Napoleão-Pêgo P, Villela LM, Côrtes FH, Cardoso SW, Hoagland B, Grinsztejn B, Veloso VG, De-Simone SG, Guimarães ML. Caetano DG, et al. Among authors: cardoso sw. Vaccines (Basel). 2024 Jul 13;12(7):771. doi: 10.3390/vaccines12070771. Vaccines (Basel). 2024. PMID: 39066409 Free PMC article.
145 results